2022 District XI Annual District Meeting

Meeting the Challenges of Women’s Health

Product Theaters

Real-World Experience Using the BD Onclarity™ HPV Assay with Extended Genotyping

Sponsored by BD Life Sciences

Friday, September 23, 2022
11:45 a.m.–12:45 p.m. CT

Rio Grande East

In this session, you will hear about an obstetrician–gynecologist’s experience using the BD Onclarity™ HPV Assay with Extended Genotyping. There will also be a presentation with detailed information about the BD Onclarity™ assay, including indications for use, design, and supporting clinical evidence.

Speakers: Kemi Ogunjimi, MD, FACOG, and Catherine Dezynski, WHNP, CNM

Kemi Ogunjimi, MD, FACOG, is Assistant Professor of Obstetrics and Gynecology at Texas Tech Physicians, in Lubbock, Texas.

Catherine Dezynski, WHNP, CNM, is the Medical Science Liaison for the U.S. Region in Women's Health at Becton, Dickinson and Company.

Updates and Case Reviews in Pelvic Mass Risk Assessment and Ovarian Cancer

Sponsored by Fujirebio

Friday, September 23, 2022
11:45 a.m.–12:45 p.m. CT

Chula Vista

Join us for an educational lunch symposium on the use of biomarkers to guide referrals of an adnexal mass and to assist with the management of patients with ovarian cancer. The program objectives are to …

  • Provide an update on the latest guidance on assessing adnexal masses
  • Discuss diagnostic biomarkers and algorithms, including CA125, HE4, and ROMA
  • Review adnexal mass and ovarian cancer cases with audience participation

Speaker: Richard G. Moore, MD, FACOG, FACS

Register Now

Richard G. Moore, MD, FACOG, FACS is a professor at the University of Rochester and Director of Gynecologic Oncology at the University of Rochester Medical Center. Dr. Moore leads the Wilmot Cancer Institute's Gynecology Service Line and serves as Director of the Targeted Therapeutics Laboratory for Gynecologic Cancers.

Are Your Patients at Risk? Exploring Thrombotic Microangiopathies and Atypical HUS during Pregnancy

Sponsored by Alexion Pharmaceuticals

Saturday, September 24, 2022
7–8 a.m. CT

Rio Grande East

Speaker: Richard Burwick, MD, MPH, FACOG

Richard Burwick, MD, MPH, FACOG is an associate professor in the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, at the Cedars-Sinai Medical Center.

The Significance of Diagnostic Testing in Women’s Health: Prevention, Early Detection, and Management

Saturday, September 24, 2022
12:15–1:15 p.m.

Rio Grande East

Sponsored by Hologic

Please join us as we discuss real-world data reflective of current clinical practices in the United States for cervical cancer screening and Mycoplasma genitalium. We will also address ways in which we can improve patient care through established screening guidelines.

Speakers: Darren Wheeler, MD, Quest Diagnostics, and Kyle Bukowski, MD, FACOG, Planned Parenthood